Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 215

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Protein tyrosine kinase regulation by ubiquitination: Critical roles of Cbl-family ubiquitin ligases

Open access
Mohapatra, Bhopal, Ahmad, Gulzar, Nadeau, Scott, Zutshi, Neha, An, Wei, Scheffe, Sarah, Dong, Lin, Feng, Dan, Goetz, Benjamin, Arya, Priyanka, Bailey, Tameka A., Palermo, Nicholas, Borgstahl, Gloria E.O., Natarajan, Amarnath, Raja, Srikumar M., Naramura, Mayumi, Band, Vimla, Band, Hamid · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Abstract

Protein tyrosine kinases (PTKs) coordinate a broad spectrum of cellular responses to extracellular stimuli and cell–cell interactions during development, tissue homeostasis, and responses to environmental challenges. Thus, an understanding of the regulatory mechanisms that ensure physiological PTK function and potential aberrations of these regulatory processes during diseases such as cancer are of broad interest in biology and medicine. Aside from the expected role of phospho-tyrosine phosphatases, recent studies have revealed a critical role of covalent modification of activated PTKs with ubiquitin as a critical mechanism of their negative regulation. Members of the Cbl protein family (Cbl, Cbl-b and Cbl-c in mammals) have emerged as dominant “activated PTK-selective” ubiquitin ligases. Structural, biochemical and cell biological studies have established that Cbl protein-dependent ubiquitination targets activated PTKs for degradation either by facilitating their endocytic sorting into lysosomes or by promoting their proteasomal degradation. This mechanism also targets PTK signaling intermediates that become associated with Cbl proteins in a PTK activation-dependent manner. Cellular and animal studies have established that the relatively broadly expressed mammalian Cbl family members Cbl and Cbl-b play key physiological roles, including their critical functions to prevent the transition of normal immune responses into autoimmune disease and as tumor suppressors; the latter function has received validation from human studies linking mutations in Cbl to human leukemia. These newer insights together with embryonic lethality seen in mice with a combined deletion of Cbl and Cbl-b genes suggest an unappreciated role of the Cbl family proteins, and by implication the ubiquitin-dependent control of activated PTKs, in stem/progenitor cell maintenance. Future studies of existing and emerging animal models and their various cell lineages should help test the broader implications of the evolutionarily-conserved Cbl family protein-mediated, ubiquitin-dependent, negative regulation of activated PTKs in physiology and disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbamcr.2012.10.010

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 210

  1. Hunter, 2009, Tyrosine phosphorylation: thirty years and counting, Curr. Opin. Cell Biol., 21, 140, 10.1016/j.ceb.2009.01.028 · DOI · Paper page
  2. Weiss, 2010, The right team at the right time to go for a home run: tyrosine kinase activation by the TCR, Nat. Immunol., 11, 101, 10.1038/ni0210-101 · DOI
  3. Hendriks, 2008, Protein tyrosine phosphatases: functional inferences from mouse models and human diseases, FEBS J., 275, 816, 10.1111/j.1742-4658.2008.06249.x · DOI
  4. Julien, 2011, Inside the human cancer tyrosine phosphatome, Nat. Rev. Cancer, 11, 35, 10.1038/nrc2980 · DOI · Paper page
  5. Carpenter, 2000, The EGF receptor: a nexus for trafficking and signaling, Bioessays, 22, 697, 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.0.CO;2-1 · DOI · Paper page
  6. Waterman, 2001, Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases, FEBS Lett., 490, 142, 10.1016/S0014-5793(01)02117-2 · DOI · Paper page
  7. Wells, 1990, Ligand-induced transformation by a noninternalizing epidermal growth factor receptor, Science, 247, 962, 10.1126/science.2305263 · DOI · Paper page
  8. Hynes, 2005, ERBB receptors and cancer: the complexity of targeted inhibitors, Nat. Rev. Cancer, 5, 341, 10.1038/nrc1609 · DOI · Paper page
  9. Harari, 2000, Molecular mechanisms underlying ErbB2/HER2 action in breast cancer, Oncogene, 19, 6102, 10.1038/sj.onc.1203973 · DOI · Paper page
  10. McClintock, 2010, Transforming growth factor-{alpha} enhances corneal epithelial cell migration by promoting EGFR recycling, Invest. Ophthalmol. Vis. Sci., 51, 3455, 10.1167/iovs.09-4386 · DOI
  11. Ouyang, 1999, Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor, J. Cell. Physiol., 179, 52, 10.1002/(SICI)1097-4652(199904)179:1<52::AID-JCP7>3.0.CO;2-M · doi:10.1002/(sici)1097-4652(199904)179:1<52::aid-jcp7>3.0.co;2-m
  12. Roepstorff, 2009, Differential effects of EGFR ligands on endocytic sorting of the receptor, Traffic, 10, 1115, 10.1111/j.1600-0854.2009.00943.x · DOI · Paper page
  13. Sigismund, 2008, Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation, Dev. Cell, 15, 209, 10.1016/j.devcel.2008.06.012 · DOI · Paper page
  14. Di Fiore, 2001, Endocytosis and signaling. An inseparable partnership, Cell, 106, 1, 10.1016/S0092-8674(01)00428-7 · DOI · Paper page
  15. Barker, 2002, Retrograde signaling by the neurotrophins follows a well-worn trk, Trends Neurosci., 25, 379, 10.1016/S0166-2236(02)02199-9 · DOI
  16. McPherson, 2001, Signaling on the endocytic pathway, Traffic, 2, 375, 10.1034/j.1600-0854.2001.002006375.x · DOI · Paper page
  17. Seto, 2002, When cell biology meets development: endocytic regulation of signaling pathways, Genes Dev., 16, 1314, 10.1101/gad.989602 · DOI · Paper page
  18. Burke, 2001, Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking, Mol. Biol. Cell, 12, 1897, 10.1091/mbc.12.6.1897 · DOI · Paper page
  19. Qui, 1992, PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity, Neuron, 9, 705, 10.1016/0896-6273(92)90033-A · DOI · Paper page
  20. Pasic, 2011, Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue, Genes Dev., 25, 1641, 10.1101/gad.2025611 · DOI
  21. Vieira, 1996, Control of EGF receptor signaling by clathrin-mediated endocytosis, Science, 274, 2086, 10.1126/science.274.5295.2086 · DOI · Paper page
  22. Teis, 2002, Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction, Dev. Cell, 3, 803, 10.1016/S1534-5807(02)00364-7 · DOI · Paper page
  23. Wunderlich, 2001, A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment, J. Cell Biol., 152, 765, 10.1083/jcb.152.4.765 · DOI · Paper page
  24. Bild, 2002, Cytoplasmic transport of Stat3 by receptor-mediated endocytosis, EMBO J., 21, 3255, 10.1093/emboj/cdf351 · DOI
  25. Panopoulou, 2002, Early endosomal regulation of Smad-dependent signaling in endothelial cells, J. Biol. Chem., 277, 18046, 10.1074/jbc.M107983200 · DOI · Paper page
  26. Pierce, 2001, New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades, Oncogene, 20, 1532, 10.1038/sj.onc.1204184 · DOI · Paper page
  27. Pennock, 2003, Stimulation of cell proliferation by endosomal epidermal growth factor receptor as revealed through two distinct phases of signaling, Mol. Cell. Biol., 23, 5803, 10.1128/MCB.23.16.5803-5815.2003 · DOI
  28. Wang, 2002, Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival, Mol. Cell. Biol., 22, 7279, 10.1128/MCB.22.20.7279-7290.2002 · DOI · Paper page
  29. Wiley, 1991, The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor, J. Biol. Chem., 266, 11083, 10.1016/S0021-9258(18)99131-3 · DOI · Paper page
  30. Schulman, 2009, Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways, Nat. Rev. Mol. Cell Biol., 10, 319, 10.1038/nrm2673 · DOI · Paper page
  31. Macgurn, 2012, Ubiquitin and membrane protein turnover: from cradle to grave, Annu. Rev. Biochem., 81, 231, 10.1146/annurev-biochem-060210-093619 · DOI · Paper page
  32. Wegner, 2011, ESCRT proteins and cell signalling, Traffic, 12, 1291, 10.1111/j.1600-0854.2011.01210.x · DOI
  33. Henne, 2011, The ESCRT pathway, Dev. Cell, 21, 77, 10.1016/j.devcel.2011.05.015 · DOI · Paper page
  34. Babst, 2011, MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between, Curr. Opin. Cell Biol., 23, 452, 10.1016/j.ceb.2011.04.008 · DOI · Paper page
  35. Rusten, 2011, Shaping development with ESCRTs, Nat. Cell Biol., 14, 38, 10.1038/ncb2381 · DOI
  36. Shields, 2011, How ubiquitin functions with ESCRTs, Traffic, 12, 1306, 10.1111/j.1600-0854.2011.01242.x · DOI · Paper page
  37. Mizuno, 2005, Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes, Mol. Biol. Cell, 16, 5163, 10.1091/mbc.E05-06-0560 · DOI · Paper page
  38. Row, 2006, The ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor down-regulation, J. Biol. Chem., 281, 12618, 10.1074/jbc.M512615200 · DOI · Paper page
  39. Wright, 2011, Regulation of endocytic sorting by ESCRT-DUB-mediated deubiquitination, Cell Biochem. Biophys., 60, 39, 10.1007/s12013-011-9181-9 · DOI
  40. McCullough, 2006, Activation of the endosome-associated ubiquitin isopeptidase AMSH by STAM, a component of the multivesicular body-sorting machinery, Curr. Biol., 16, 160, 10.1016/j.cub.2005.11.073 · DOI · Paper page
  41. Ma, 2007, Targeting of AMSH to endosomes is required for epidermal growth factor receptor degradation, J. Biol. Chem., 282, 9805, 10.1074/jbc.M611635200 · DOI
  42. Row, 2007, The MIT domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient epidermal growth factor receptor degradation, J. Biol. Chem., 282, 30929, 10.1074/jbc.M704009200 · DOI · Paper page
  43. Wu, 2004, Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8, Mol. Cell. Biol., 24, 7748, 10.1128/MCB.24.17.7748-7757.2004 · DOI · Paper page
  44. Meenhuis, 2011, The deubiquitinating enzyme DUB2A enhances CSF3 signalling by attenuating lysosomal routing of the CSF3 receptor, Biochem. J., 434, 343, 10.1042/BJ20101628 · DOI
  45. Z. Liu, S.M. Zanata, J. Kim, M.A. Peterson, D. Di Vizio, L.R. Chirieac, S. Pyne, M. Agostini, M.R. Freeman, M. Loda, The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation, Oncogene (in press) (Epub ahead of print, Jun 18 2012). · DOI
  46. Pareja, 2012, Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression, Oncogene, 31, 4599, 10.1038/onc.2011.587 · DOI
  47. Harhaj, 2012, Regulation of NF-kappaB by deubiquitinases, Immunol. Rev., 246, 107, 10.1111/j.1600-065X.2012.01100.x · DOI · Paper page
  48. Lu, 2009, Degradation of activated protein kinases by ubiquitination, Annu. Rev. Biochem., 78, 435, 10.1146/annurev.biochem.013008.092711 · DOI
  49. Mori, 1992, Ligand-induced polyubiquitination of the platelet-derived growth factor beta-receptor, J. Biol. Chem., 267, 6429, 10.1016/S0021-9258(18)42714-7 · DOI · Paper page
  50. Langdon, 1989, v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas, Proc. Natl. Acad. Sci. U.S.A., 86, 1168, 10.1073/pnas.86.4.1168 · DOI · Paper page
  51. Blake, 1993, The truncation that generated the v-cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation, EMBO J., 12, 2017, 10.1002/j.1460-2075.1993.tb05851.x · DOI
  52. Meng, 1999, Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase, Nature, 398, 84, 10.1038/18050 · DOI · Paper page
  53. Zheng, 2000, Structure of a c-Cbl–UbcH7 complex: RING domain function in ubiquitin–protein ligases, Cell, 102, 533, 10.1016/S0092-8674(00)00057-X · DOI · Paper page
  54. Ota, 2000, The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase, J. Biol. Chem., 275, 414, 10.1074/jbc.275.1.414 · DOI
  55. Lill, 2000, The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor, J. Biol. Chem., 275, 367, 10.1074/jbc.275.1.367 · DOI
  56. Lupher, 1999, The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction, Immunol. Today, 20, 375, 10.1016/S0167-5699(99)01484-X · DOI
  57. Naramura, 2011, Indispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling: insights from in vivo models, Commun. Integr. Biol., 4, 159, 10.4161/cib.4.2.14716 · DOI
  58. Naramura, 2011, Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders, Oncotarget, 2, 245, 10.18632/oncotarget.233 · DOI
  59. Duan, 2004, The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling, Immunity, 21, 7, 10.1016/j.immuni.2004.06.012 · DOI
  60. Thien, 2005, c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses, Biochem. J., 391, 153, 10.1042/BJ20050892 · DOI · Paper page
  61. Lipkowitz, 2011, RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis, Nat. Rev. Cancer, 11, 629, 10.1038/nrc3120 · DOI · Paper page
  62. Bartkiewicz, 1999, Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor, J. Biol. Chem., 274, 30887, 10.1074/jbc.274.43.30887 · doi:10.1074/jbc.274.43.30887
  63. Davies, 2004, Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b, Oncogene, 23, 7104, 10.1038/sj.onc.1207952 · DOI
  64. Peschard, 2007, Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b, Mol. Cell, 27, 474, 10.1016/j.molcel.2007.06.023 · DOI
  65. Nau, 2003, Comparative genomic organization of the cbl genes, Gene, 308, 103, 10.1016/S0378-1119(03)00471-2 · DOI
  66. Keane, 1999, Cbl-3: a new mammalian Cbl family protein, Oncogene, 18, 3365, 10.1038/sj.onc.1202753 · DOI
  67. Langenick, 2008, A Dictyostelium homologue of the metazoan Cbl proteins regulates STAT signalling, J. Cell Sci., 121, 3524, 10.1242/jcs.036798 · DOI
  68. Blake, 1991, The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif, Oncogene, 6, 653
  69. Andoniou, 1994, Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene, EMBO J., 13, 4515, 10.1002/j.1460-2075.1994.tb06773.x · DOI · Paper page
  70. Donovan, 1994, The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor, J. Biol. Chem., 269, 22921, 10.1016/S0021-9258(17)31595-8 · DOI · Paper page
  71. Reedquist, 1994, Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an Fyn/Lck Src homology 3 domain-binding protein, Proc. Natl. Acad. Sci. U.S.A., 91, 4135, 10.1073/pnas.91.10.4135 · DOI
  72. Fukazawa, 1995, The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase, J. Biol. Chem., 270, 19141, 10.1074/jbc.270.32.19141 · DOI · Paper page
  73. Rao, 2002, The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system, J. Leukoc. Biol., 71, 753, 10.1189/jlb.71.5.753 · DOI · Paper page
  74. Thien, 2001, Cbl: many adaptations to regulate protein tyrosine kinases, Nat. Rev. Mol. Cell Biol., 2, 294, 10.1038/35067100 · DOI · Paper page
  75. Tsygankov, 2001, Beyond the RING: CBL proteins as multivalent adapters, Oncogene, 20, 6382, 10.1038/sj.onc.1204781 · DOI
  76. Fukazawa, 1996, Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins, J. Biol. Chem., 271, 14554, 10.1074/jbc.271.24.14554 · DOI · Paper page
  77. Panchamoorthy, 1996, p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase, J. Biol. Chem., 271, 3187, 10.1074/jbc.271.6.3187 · DOI · Paper page
  78. Bonita, 1997, Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity, Mol. Cell. Biol., 17, 4597, 10.1128/MCB.17.8.4597 · DOI
  79. Meisner, 1995, Interactions of Cbl with Grb2 and phosphatidylinositol 3′-kinase in activated Jurkat cells, Mol. Cell. Biol., 15, 3571, 10.1128/MCB.15.7.3571 · DOI · Paper page
  80. Yoon, 1995, Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl, Science, 269, 1102, 10.1126/science.7652556 · DOI · Paper page
  81. Lupher, 1996, A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells, J. Biol. Chem., 271, 24063, 10.1074/jbc.271.39.24063 · DOI · Paper page
  82. Lupher, 1998, Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323, J. Biol. Chem., 273, 35273, 10.1074/jbc.273.52.35273 · DOI · Paper page
  83. Lupher, 1997, The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70, J. Biol. Chem., 272, 33140, 10.1074/jbc.272.52.33140 · DOI · Paper page
  84. Miyake, 1999, Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain, J. Biol. Chem., 274, 16619, 10.1074/jbc.274.23.16619 · DOI · Paper page
  85. Thien, 1997, Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl, Oncogene, 15, 2909, 10.1038/sj.onc.1201468 · DOI
  86. Miyake, 1998, The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha, Proc. Natl. Acad. Sci. U.S.A., 95, 7927, 10.1073/pnas.95.14.7927 · DOI · Paper page
  87. Hicke, 1996, Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis, Cell, 84, 277, 10.1016/S0092-8674(00)80982-4 · DOI · Paper page
  88. Terrell, 1998, A function for monoubiquitination in the internalization of a G protein-coupled receptor, Mol. Cell, 1, 193, 10.1016/S1097-2765(00)80020-9 · DOI · Paper page
  89. Abella, 2005, Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation, Mol. Cell. Biol., 25, 9632, 10.1128/MCB.25.21.9632-9645.2005 · DOI · Paper page
  90. Lee, 1999, The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation, EMBO J., 18, 3616, 10.1093/emboj/18.13.3616 · DOI · Paper page
  91. Peschard, 2001, Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein, Mol. Cell, 8, 995, 10.1016/S1097-2765(01)00378-1 · DOI · Paper page
  92. Rao, 2002, An essential role of ubiquitination in Cbl-mediated negative regulation of the Src-family kinase Fyn, Signal Transduct., 2, 29, 10.1002/1615-4061(200205)2:1/2<29::AID-SITA29>3.0.CO;2-7 · doi:10.1002/1615-4061(200205)2:1/2<29::aid-sita29>3.0.co;2-7
  93. Rao, 2001, The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation, EMBO J., 20, 7085, 10.1093/emboj/20.24.7085 · DOI
  94. Rao, 2002, Negative regulation of Lck by Cbl ubiquitin ligase, Proc. Natl. Acad. Sci. U.S.A., 99, 3794, 10.1073/pnas.062055999 · DOI
  95. Rao, 2000, The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells, J. Immunol., 164, 4616, 10.4049/jimmunol.164.9.4616 · DOI
  96. Joazeiro, 1999, The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin–protein ligase, Science, 286, 309, 10.1126/science.286.5438.309 · DOI · Paper page
  97. Levkowitz, 1999, Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1, Mol. Cell, 4, 1029, 10.1016/S1097-2765(00)80231-2 · DOI · Paper page
  98. Ettenberg, 2001, Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex, J. Biol. Chem., 276, 27677, 10.1074/jbc.M102641200 · DOI · Paper page
  99. Kim, 2004, Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation, Oncogene, 23, 1645, 10.1038/sj.onc.1207298 · DOI
  100. Ryan, 2010, The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme, J. Biol. Chem., 285, 23687, 10.1074/jbc.M109.091157 · DOI
  101. Kales, 2012, Cbl exposes its RING finger, Nat. Struct. Mol. Biol., 19, 131, 10.1038/nsmb.2241 · DOI
  102. Ng, 2008, Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates, EMBO J., 27, 804, 10.1038/emboj.2008.18 · DOI
  103. Penengo, 2003, c-Cbl is a critical modulator of the Ron tyrosine kinase receptor, Oncogene, 22, 3669, 10.1038/sj.onc.1206585 · doi:10.1038/sj.onc.1206585
  104. Peschard, 2004, A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation, J. Biol. Chem., 279, 29565, 10.1074/jbc.M403954200 · DOI
  105. Hu, 2005, Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins, J. Biol. Chem., 280, 18943, 10.1074/jbc.M414157200 · DOI
  106. Masson, 2006, Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation, Biochem. J., 399, 59, 10.1042/BJ20060464 · DOI
  107. Wu, 2003, Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase, Mol. Cell, 11, 1445, 10.1016/S1097-2765(03)00234-X · DOI · Paper page
  108. Thien, 2001, RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation, Mol. Cell, 7, 355, 10.1016/S1097-2765(01)00183-6 · DOI · Paper page
  109. Kobashigawa, 2011, Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b, Proc. Natl. Acad. Sci. U.S.A., 108, 20579, 10.1073/pnas.1110712108 · DOI
  110. Dou, 2012, Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl, Nat. Struct. Mol. Biol., 19, 184, 10.1038/nsmb.2231 · DOI · Paper page
  111. Schmidt, 2003, Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization, Proc. Natl. Acad. Sci. U.S.A., 100, 6505, 10.1073/pnas.1031790100 · DOI · Paper page
  112. Ghosh, 2004, Biochemical basis for the requirement of kinase activity for Cbl-dependent ubiquitinylation and degradation of a target tyrosine kinase, J. Biol. Chem., 279, 36132, 10.1074/jbc.M404189200 · DOI
  113. Kassenbrock, 2004, Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations, J. Biol. Chem., 279, 28017, 10.1074/jbc.M404114200 · DOI
  114. Rosenkranz, 2000, Src family kinases negatively regulate platelet-derived growth factor alpha receptor-dependent signaling and disease progression, J. Biol. Chem., 275, 9620, 10.1074/jbc.275.13.9620 · DOI
  115. Liu, 2002, Cbl and Cbl-b in T-cell regulation, Trends Immunol., 23, 140, 10.1016/S1471-4906(01)02157-3 · DOI
  116. Miura-Shimura, 2003, Cbl-mediated ubiquitinylation and negative regulation of Vav, J. Biol. Chem., 278, 38495, 10.1074/jbc.M305656200 · DOI
  117. Zhang, 2003, Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b, J. Biol. Chem., 278, 23978, 10.1074/jbc.M212671200 · DOI
  118. d'Azzo, 2005, E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation, Traffic, 6, 429, 10.1111/j.1600-0854.2005.00294.x · DOI · Paper page
  119. Haglund, 2003, Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation, Nat. Cell Biol., 5, 461, 10.1038/ncb983 · DOI · Paper page
  120. Levkowitz, 1998, c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor, Genes Dev., 12, 3663, 10.1101/gad.12.23.3663 · DOI · Paper page
  121. Umebayashi, 2008, Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation, Mol. Biol. Cell, 19, 3454, 10.1091/mbc.E07-10-0988 · DOI
  122. Fasen, 2008, Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway, Traffic, 9, 251, 10.1111/j.1600-0854.2007.00679.x · DOI
  123. Huang, 2006, Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain, Mol. Cell, 21, 737, 10.1016/j.molcel.2006.02.018 · DOI · Paper page
  124. Longva, 2002, Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies, J. Cell Biol., 156, 843, 10.1083/jcb.200106056 · DOI · Paper page
  125. Huang, 2010, Roles of E3 ubiquitin ligases in cell adhesion and migration, Cell Adh. Migr., 4, 10, 10.4161/cam.4.1.9834 · DOI
  126. Ryan, 2006, Regulating the regulator: negative regulation of Cbl ubiquitin ligases, Trends Biochem. Sci., 31, 79, 10.1016/j.tibs.2005.12.004 · DOI
  127. Soubeyran, 2002, Cbl-CIN85–endophilin complex mediates ligand-induced downregulation of EGF receptors, Nature, 416, 183, 10.1038/416183a · DOI · Paper page
  128. Petrelli, 2002, The endophilin–CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met, Nature, 416, 187, 10.1038/416187a · DOI · Paper page
  129. Duan, 2003, Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis, J. Biol. Chem., 278, 28950, 10.1074/jbc.M304474200 · DOI · Paper page
  130. Khan, 2006, Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking, J. Biol. Chem., 281, 14486, 10.1074/jbc.M509332200 · DOI · Paper page
  131. Huang, 2007, EGF receptor ubiquitination is not necessary for its internalization, Proc. Natl. Acad. Sci. U.S.A., 104, 16904, 10.1073/pnas.0707416104 · DOI · Paper page
  132. Goh, 2010, Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor, J. Cell Biol., 189, 871, 10.1083/jcb.201001008 · DOI · Paper page
  133. Swaminathan, 2006, The Cbl family proteins: ring leaders in regulation of cell signaling, J. Cell. Physiol., 209, 21, 10.1002/jcp.20694 · DOI · Paper page
  134. Miura, 2003, Cbl PYXXM motifs activate the P85 subunit of phosphatidylinositol 3-kinase, Crk, atypical protein kinase C, and glucose transport during thiazolidinedione action in 3T3/L1 and human adipocytes, Biochemistry, 42, 14335, 10.1021/bi034808i · DOI
  135. Standaert, 2004, Requirements for pYXXM motifs in Cbl for binding to the p85 subunit of phosphatidylinositol 3-kinase and Crk, and activation of atypical protein kinase C and glucose transport during insulin action in 3T3/L1 adipocytes, Biochemistry, 43, 15494, 10.1021/bi049222q · DOI
  136. Goh, 2002, c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription, Endocrinology, 143, 3590, 10.1210/en.2002-220374 · doi:10.1210/en.2002-220374
  137. Wang, 2002, Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation, Oncogene, 21, 5346, 10.1038/sj.onc.1205670 · DOI
  138. Timpson, 2005, Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor, Cancer Res., 65, 3273, 10.1158/0008-5472.CAN-04-2118 · DOI
  139. Fong, 2003, Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function, J. Biol. Chem., 278, 33456, 10.1074/jbc.M301317200 · DOI
  140. Wong, 2002, Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling, EMBO J., 21, 4796, 10.1093/emboj/cdf493 · DOI · Paper page
  141. Wong, 2006, Regulator of epidermal growth factor signaling: Sprouty, Methods Mol. Biol., 327, 61
  142. Wiedemann, 2005, T-cell activation is accompanied by an ubiquitination process occurring at the immunological synapse, Immunol. Lett., 98, 57, 10.1016/j.imlet.2004.10.014 · DOI
  143. Naramura, 2002, c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation, Nat. Immunol., 3, 1192, 10.1038/ni855 · DOI · Paper page
  144. Rathinam, 2008, The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells, Genes Dev., 22, 992, 10.1101/gad.1651408 · DOI
  145. Rathinam, 2010, Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling, Cancer Cell, 18, 341, 10.1016/j.ccr.2010.09.008 · DOI
  146. Naramura, 2010, Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells, Proc. Natl. Acad. Sci. U.S.A., 107, 16274, 10.1073/pnas.1007575107 · DOI
  147. Ledda, 2007, Negative regulation of receptor tyrosine kinase (RTK) signaling: a developing field, Biomark. Insights, 2, 45, 10.1177/117727190700200029 · DOI
  148. Segatto, 2011, Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors, J. Cell Sci., 124, 1785, 10.1242/jcs.083303 · DOI
  149. Ahmed, 2008, Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth, J. Natl. Cancer Inst., 100, 1606, 10.1093/jnci/djn365 · DOI
  150. Gur, 2004, LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation, EMBO J., 23, 3270, 10.1038/sj.emboj.7600342 · DOI · Paper page
  151. Frosi, 2010, A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation, J. Cell Biol., 189, 557, 10.1083/jcb.201002032 · DOI · Paper page
  152. Schmid, 2007, Integrating molecular and network biology to decode endocytosis, Nature, 448, 883, 10.1038/nature06031 · DOI · Paper page
  153. Nicholson, 2005, Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling, Proc. Natl. Acad. Sci. U.S.A., 102, 2328, 10.1073/pnas.0409675102 · DOI
  154. Kario, 2005, Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling, J. Biol. Chem., 280, 7038, 10.1074/jbc.M408575200 · DOI
  155. Tanaka, 2008, c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130, Mol. Cell. Biol., 28, 4805, 10.1128/MCB.01784-07 · DOI
  156. Tarcic, 2009, An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis, Curr. Biol., 19, 1788, 10.1016/j.cub.2009.09.048 · DOI
  157. Guy, 2009, Sprouty proteins: modified modulators, matchmakers or missing links?, J. Endocrinol., 203, 191, 10.1677/JOE-09-0110 · DOI
  158. Hanafusa, 2002, Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway, Nat. Cell Biol., 4, 850, 10.1038/ncb867 · DOI · Paper page
  159. Sasaki, 2003, Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1, Nat. Cell Biol., 5, 427, 10.1038/ncb978 · DOI · Paper page
  160. Wong, 2001, Evidence for direct interaction between Sprouty and Cbl, J. Biol. Chem., 276, 5866, 10.1074/jbc.M006945200 · DOI
  161. Hall, 2003, hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl, Curr. Biol., 13, 308, 10.1016/S0960-9822(03)00086-1 · DOI
  162. Rubin, 2003, Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops, Curr. Biol., 13, 297, 10.1016/S0960-9822(03)00053-8 · DOI · Paper page
  163. Egan, 2002, The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins, Proc. Natl. Acad. Sci. U.S.A., 99, 6041, 10.1073/pnas.052090899 · DOI
  164. Choi, 2006, Dual effects of Sprouty1 on TCR signaling depending on the differentiation state of the T cell, J. Immunol., 176, 6034, 10.4049/jimmunol.176.10.6034 · DOI
  165. Meisner, 1997, Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development, Mol. Cell. Biol., 17, 2217, 10.1128/MCB.17.4.2217 · DOI
  166. Pai, 2000, D-cbl, a negative regulator of the Egfr pathway, is required for dorsoventral patterning in Drosophila oogenesis, Cell, 103, 51, 10.1016/S0092-8674(00)00104-5 · DOI
  167. Nowak, 2011, Interpretation of the FGF8 morphogen gradient is regulated by endocytic trafficking, Nat. Cell Biol., 13, 153, 10.1038/ncb2155 · DOI
  168. Murphy, 1998, Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice, Mol. Cell. Biol., 18, 4872, 10.1128/MCB.18.8.4872 · DOI · Paper page
  169. Naramura, 1998, Altered thymic positive selection and intracellular signals in Cbl-deficient mice, Proc. Natl. Acad. Sci. U.S.A., 95, 15547, 10.1073/pnas.95.26.15547 · DOI · Paper page
  170. El Chami, 2005, Androgen-dependent apoptosis in male germ cells is regulated through the proto-oncoprotein Cbl, J. Cell Biol., 171, 651, 10.1083/jcb.200507076 · DOI
  171. Molero, 2004, c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action, J. Clin. Invest., 114, 1326, 10.1172/JCI21480 · DOI
  172. Bachmaier, 2000, Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b, Nature, 403, 211, 10.1038/35003228 · DOI · Paper page
  173. Chiang, 2000, Cbl-b regulates the CD28 dependence of T-cell activation, Nature, 403, 216, 10.1038/35003235 · DOI · Paper page
  174. Nakao, 2009, Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading, Mol. Cell. Biol., 29, 4798, 10.1128/MCB.01347-08 · DOI · Paper page
  175. Griffiths, 2003, Cbl-3-deficient mice exhibit normal epithelial development, Mol. Cell. Biol., 23, 7708, 10.1128/MCB.23.21.7708-7718.2003 · DOI
  176. Langdon, 1989, The c-cbl proto-oncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein, J. Virol., 63, 5420, 10.1128/JVI.63.12.5420-5424.1989 · DOI
  177. Kitaura, 2007, Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b, Immunity, 26, 567, 10.1016/j.immuni.2007.03.015 · DOI
  178. Sargin, 2007, Flt3-dependent transformation by inactivating c-Cbl mutations in AML, Blood, 110, 1004, 10.1182/blood-2007-01-066076 · DOI · Paper page
  179. Caligiuri, 2007, Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia, Blood, 110, 1022, 10.1182/blood-2006-12-061176 · DOI
  180. Makishima, 2009, Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies, J. Clin. Oncol., 27, 6109, 10.1200/JCO.2009.23.7503 · DOI · Paper page
  181. Brecqueville, 2012, Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms, Genes Chromosomes Cancer, 51, 743, 10.1002/gcc.21960 · DOI · Paper page
  182. Kao, 2011, A high occurrence of acquisition and/or expansion of C-CBL mutant clones in the progression of high-risk myelodysplastic syndrome to acute myeloid leukemia, Neoplasia, 13, 1035, 10.1593/neo.111192 · DOI
  183. Nicholson, 2012, Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia, Genes Chromosomes Cancer, 51, 250, 10.1002/gcc.20949 · DOI
  184. Saito, 2012, Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia, Leuk. Res., 36, 1009, 10.1016/j.leukres.2012.04.018 · DOI
  185. Schnittger, 2012, Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myeloproliferative/myelodysplastic disorders: an analysis of 636 cases, Haematologica, 10.3324/haematol.2012.065375 · doi:10.3324/haematol.2012.065375
  186. Shiba, 2010, CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome, Leukemia, 24, 1090, 10.1038/leu.2010.49 · doi:10.1038/leu.2010.49
  187. Sanada, 2009, Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms, Nature, 460, 904, 10.1038/nature08240 · DOI · Paper page
  188. Grand, 2009, Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms, Blood, 113, 6182, 10.1182/blood-2008-12-194548 · DOI · Paper page
  189. Bandi, 2009, Study Alliance Leukemias, E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease, Blood, 114, 4197, 10.1182/blood-2008-12-190934 · DOI
  190. Liu, 2012, Molecular targets for the treatment of juvenile myelomonocytic leukemia, Adv. Hematol., 2012, 308252, 10.1155/2012/308252 · DOI
  191. Mao, 2010, As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia, Proc. Natl. Acad. Sci. U.S.A., 107, 21683, 10.1073/pnas.1016311108 · DOI
  192. Makishima, 2012, CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors, Leukemia, 26, 1547, 10.1038/leu.2012.7 · doi:10.1038/leu.2012.7
  193. Loh, 2010, Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia, Hematol. Am. Soc. Hematol. Educ. Program., 2010, 357, 10.1182/asheducation-2010.1.357 · DOI
  194. Tan, 2010, CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases, PLoS One, 5, e8972, 10.1371/journal.pone.0008972 · DOI
  195. Li, 2007, Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function, PLoS Biol., 5, e35, 10.1371/journal.pbio.0050035 · DOI
  196. Ferron, 2010, Regulated segregation of kinase Dyrk1A during asymmetric neural stem cell division is critical for EGFR-mediated biased signaling, Cell Stem Cell, 7, 367, 10.1016/j.stem.2010.06.021 · DOI
  197. Doniz-Padilla, 2011, Expression and function of Cbl-b in T cells from patients with systemic lupus erythematosus, and detection of the 2126 A/G Cblb gene polymorphism in the Mexican mestizo population, Lupus, 20, 628, 10.1177/0961203310394896 · DOI
  198. Yokoi, 2002, Cblb is a major susceptibility gene for rat type 1 diabetes mellitus, Nat. Genet., 31, 391, 10.1038/ng927 · DOI · Paper page
  199. Yokoi, 2007, Genetic reconstitution of autoimmune type 1 diabetes with two major susceptibility genes in the rat, Diabetes, 56, 506, 10.2337/db06-1027 · DOI
  200. Singh, 2007, A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis, Proc. Natl. Acad. Sci. U.S.A., 104, 5413, 10.1073/pnas.0700809104 · DOI

200 of 210 shown

Cited by

See all 215

Metadata

Authors
Mohapatra, B., Ahmad, G., Nadeau, S., Zutshi, N., An, W., Scheffe, S., Dong, L., Feng, D., Goetz, B., Arya, P., Bailey, T. A., Palermo, N., Borgstahl, G. E. O., Natarajan, A., Raja, S. M., Naramura, M., Band, V., & Band, H.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Publisher
Elsevier BV
Published
2013-01
Volume
1833
Issue
1
Pages
122-139
ISSN
0167-4889 (ISSN-L)
OpenAlex
W2096483233
Cited by
215
References
8
FWCI
4.76
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • NIH (CA87986, CA105489, CA99163, CA116552, CA96844, CA144027)
  • NCI (5U01CA151806-02)
  • Department of Defense (W81WH-11-1-0167, W81XWH-07-1-0351, W81XWH-11-1-0171)
  • UNMC
  • NCI Institutional Cancer Biology Training Grant (CA009476)
  • China Scholarship Council
  • China Medical University Shenyang, China
  • Susan G. Komen Foundation
  • UNMC Diversity Fund

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protein tyrosine kinase regulation by ubiquitination: Critical roles of Cbl-family ubiquitin ligases. https://app.cochat.ai/papers/10.1016/j.bbamcr.2012.10.010
The paper
Mohapatra, B., Ahmad, G., Nadeau, S., Zutshi, N., An, W., Scheffe, S., Dong, L., Feng, D., Goetz, B., Arya, P., Bailey, T. A., Palermo, N., Borgstahl, G. E. O., Natarajan, A., Raja, S. M., Naramura, M., Band, V., & Band, H. (2013). Protein tyrosine kinase regulation by ubiquitination: Critical roles of Cbl-family ubiquitin ligases. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. https://doi.org/10.1016/j.bbamcr.2012.10.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.